Skip to main content

Niravam FDA Approval History

FDA Approved: Yes (Discontinued) (First approved January 19, 2005)
Brand name: Niravam
Generic name: alprazolam
Dosage form: Orally Disintegrating Tablets
Company: UCB, Inc.
Treatment for: Anxiety, Panic Disorder

Marketing Status: Discontinued

Niravam (alprazolam) is an orally disintegrating benzodiazepine indicated for the short-term relief of anxiety and panic attacks.

Development timeline for Niravam

Jan 19, 2005Approval Niravam Schwarz Pharma AG - Treatment for Anxiety Disorders

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.